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Tbjective: Postoperative atrial fibrillation is one of the most frequent complications
f cardiac surgery. We developed a novel biodegradable gel pad consisting of
iopolymers that directly attach to the myocardium by electrostatic interaction. The
resent study examines the feasibility and effectiveness of low-energy internal
ardioversion using these pads.
ethods: The hearts of 6 pigs were exposed through a median sternotomy under
eneral anesthesia, and 2 monopolar pacing wires were placed on the left pulmonary
eins (chest open group). Two biodegradable cardioversion gel pads were placed on the
ight appendage and the left atria without suturing. All wires were extruded through the
kin and secured with a suture. Sustained atrial fibrillation was induced by burst-pacing
rom the pulmonary veins in continuous 20-ms cycles. Shock intensity started at 0.5 J,
nd the energy level was increased in 0.5-J increments until cardioversion occurred. This
rotocol was repeated 5 times per pig. In a second group of 6 pigs (chest closed group),
he epicardial cardioversion electrode gel pads and pacing wire electrodes were posi-
ioned as described above. Shock intensity was started at 0.5 J. If the shock was
nsuccessful, the energy level was increased in 0.5-J increments until 2 consecutive
ardioversions were achieved at a single energy level. At postoperative days 1, 3, 5, and
, the defibrillation threshold was determined with the chest closed. At postoperative day
0, the cardioversion wires were removed. At predetermined time intervals, the heart
as reexposed and the extent of degradation in vivo was visually evaluated and
istologically assessed after sacrifice.
esults: All pigs with induced atrial fibrillation were cardioverted to sinus rhythm
n the determined postoperative day. The mean energy and lead impedance in the
hest open group were 0.65  0.23 J and 97.6  5.52 , respectively, and the
verall values of mean energy and lead impedance in the chest closed group were
.67  1.00 J and 75.9  13.3, respectively. No complications were observed
fter wire removal. The gel pads became degraded and decreased in thickness, and
igns of mild inflammation were evident on the gel pad. However, the gel pads
id not elicit significant severe inflammatory reactions according to both gross and
istologic assessments at 1 month after the surgery.
onclusion: Atrial cardioversion using novel biodegradable gel pads that are easily
ffixed may afford a straightforward and effective treatment for atrial fibrillation
fter cardiac surgery.
trial fibrillation (AF) is one of the most common complications after cardiac
surgery. Postoperative incidence varies between 20% and 60% within the
first week.1-5 The onset of postoperative AF might result in an incre
isk for stroke, hemodynamic deterioration, prolonged hospital stay, and associated
ost.6-8
he Journal of Thoracic and Cardiovascular Surgery ● Volume 134, Number 6 1519
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1
ETCurrent treatment for postoperative AF consists of antiar-
hythmic and anticoagulation drugs that may have consider-
ble side effects.9 When AF results in hemodynamic instabil
hat requires transthoracic cardioversion under general anes-
hesia, new arrhythmias, burns and pain to the patient, and
roblems associated with anesthesia might arise. Therefore,
everal investigators have attempted internal cardioversion us-
ng temporary epicardial defibrillation leads as an alternative to
xternal transthoracic cardioversion to treat postoperative
F.10-14 The benefits of this therapy are a low-energy req-
ent for cardioversion, reduced myocardial damage from
hock, minimized pain associated with energy delivery, and
lective general anesthesia. However, securing leads on the
ight and left atria using S-, O-, or linear-shaped sutures is
wkward and time-consuming, especially during off-pump
urgery. Furthermore, extracting the leads increases the poten-
ial for bleeding.
Therefore, we developed a novel biodegradable biopolymer
el pad that directly attaches to the myocardial surface by
lectrostatic interaction. The custom-made cardioversion elec-
rode consisted of a biodegradable gel pad and a spiral stainless
teel wire (temporary myocardial lead, TME61Z, Dr Osypka,
MBH Medizintechnik, Rheinfelden-Herten, Germany) with
n insulated portion (Figure 1). The present study examine
easibility and effectiveness of low-energy internal cardiover-
ion using our novel biodegradable gel pads.
aterials and Methods
aterials
yaluronic acid sodium salt (HA: sodium salt; average molecular
eight, 1150 kDa; produced by Streptococcus mutants of lactic
cid bacteria) and poly (-L-lysine; EPL: average molecular
eight, 3.8 kDa) were supplied by Chisso Co Ltd (Tokyo, Japan).
e used 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydro-
hloride (Dojindo Laboratories, Kumamoto, Japan), a water-solu-
le carbodiimide, as a crosslinker.
anufacture of Electrode Gel Pads
ixtures of 2 wt% each of HA and EPL (molar ratio of HA:EPL,
:2) or 4 wt% each of HA and EPL (molar ratio of HA:EPL, 1:2)
n double-distilled water were adjusted with 1 N HCl to pH 7.0. A
ardioversion wire with a spiral distal end was immersed in a
ircular Teflon (diameter, 40 mm; depth, 4 mm) mold containing
he polyelectrolyte solutions, frozen in liquid nitrogen, and then
reeze-dried using a lyophilizer (FreeZone 6, Labconco Corp,
Abbreviations and Acronyms
AF  atrial fibrillation
EPL  epsilon polylysine
HA  hyaluronic acid
POD postoperative day
PV  pulmonary veinansas City, Mo). The cardioversion wire embedded in white s
520 The Journal of Thoracic and Cardiovascular Surgery ● Decolids was crosslinked by immersion in a mixture of 80 vol%
thanol and 20 vol% water containing 50 mmol/L water-soluble
arbodiimide for 24 hours at 25°C and then washed in double-
istilled water. The chemical crosslinking is based on the
ctivation of carboxylic sites with primary amine groups. The
nal product was a spongy, discoid HA-EPL crosslinked elec-
rode gel pad 40 mm in diameter and 4 mm thick.
xperimental Protocol
he 12 pigs (weight, 30 to 42 kg; average, 36.0  2.2 kg) used in
his study received humane care in accordance with the Principles
f Laboratory Animal Care formulated by the National Society for
edical Research and the Guide for the Care and Use of Labo-
atory Animals prepared by the Institute of Laboratory Animal
esources, National Research Council (National Academy Press;
evised 1996). AF (5 minutes) was induced by pulmonary vein
PV) burst pacing and sustained in all 12 pigs. Phase I of this study
nvestigated the feasibility of atrial defibrillation using the novel
picardial cardioversion gel pads with the chest open. Phase II
xamined the effectiveness of the novel epicardial cardioversion
lectrode gel pads implanted in a manner resembling clinical
pplication.
perative Procedure
he pigs were premedicated with an intramuscular injection of ket-
mine (10 mg/kg body weight), intubated, and anesthetized with 0.5%
o 2.5% halothane and a mixture of oxygen and nitrous oxide. Elec-
rocardiography was continuously monitored using a polygraph sys-
em (RM-6000, Nihon Koden, Tokyo, Japan) throughout the proce-
ure. The heart was exposed through a median sternotomy under
eneral anesthesia, and 2 monopolar stainless steel temporary wire
lectrodes (temporary pacing wire, Johnson & Johnson, NJ) were
laced on the left PVs for pacing and recording. Two crosslinking
iodegradable cardioversion electrode gel pads (2 and 4 wt% HA-
PL) were respectively placed on the right appendage and left atria
ithout suture (Figure 2). All wires were extruded through the
nd secured with a nonabsorbable suture.
trial Defibrillation Protocols
Phase I. We evaluated the effectiveness and safety of atrial
efibrillation generated using the novel epicardial cardioversion
lectrode gel pads on the day of surgery with the chest open in 6
igs (CO group). With the use of a heating pad, the body temper-
ture of the pigs was maintained within the normal physiologic
ange throughout the study. Electrocardiographic leads I, II, and III
nd electrograms from the left PV were monitored and recorded on
polygraph system. Sustained AF, defined as AF lasting for at
east 5 minutes, was continuously induced by burst pacing at cycle
engths of 20 ms through the left PV electrodes using a customized
brillator (Nihon Koden, Tokyo, Japan). We used an external
rogrammer (Ventak ECD, model 2815, Guidant Corporation,
anta Clara, Calif) to control defibrillation that was delivered as an
-wave–synchronized biphasic shock to the atria through the
ardioversion electrode gel pads. The shock intensity started at 0.5
and was increased in 0.5-J increments to 3 J and thereafter in 1-J
ncrements until AF was converted. This protocol was repeated 5
imes per pig. The defibrillation threshold was defined as the lowest
hock energy (voltage) required to convert AF into sinus rhythm.
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ETPhase II. A different group of 6 pigs underwent median ster-
otomy. The epicardial cardioversion electrode gel pad and pacing
emporary wire electrodes were placed as described above for the
rst phase. Burst pacing was continuously applied from the PVs at
ycle lengths of 20 ms to induce sustained AF. Cardioversion
roceeded using a biphasic defibrillation system with the chest
pen. Shock intensity started at 0.5 J and was increased by 0.5 J to
J, and thereafter 1-J step increments were applied until 2 con-
ecutive cardioversions were achieved at a single energy level. The
efibrillation threshold was defined as the lowest shock energy
voltage) required to produce 2 consecutive cardioversions. There-
fter, the pericardium was reapproximated, the sternotomy was
losed in the standard manner, and the pigs were allowed to
ecover. At postoperative days (PODs) 1, 3, 5, and 7, sustained AF
as induced by burst pacing in the sedated state, and the defibril-
ation threshold was achieved with the chest closed as before. On
OD 10, the cardioversion wires were removed from all pigs under
edation, but the electrode gel pads remained positioned around theThe Journal of Thoraciceart. After predetermined time intervals, the heart was reexposed
nd the extent of degradation in vivo was histologically evaluated
fter sacrifice. Gel pads were removed from the pigs, fixed to-
ether with surrounding tissue in 10% formalin, sectioned using a
icrotome, and stained with hematoxylin–eosin.
tatistical Analysis
ata are reported as mean  standard deviation. The change over
ime of energy, impedance, and voltage were compared by Fried-
an’s chi-square r test followed by the Wilcoxon t test with
onferroni correction.
esults
hase I
he gel pads were easily attached without suture in all 12
igs. The epicardial cardioversion electrode gel pads posi-
ioned in 6 pigs did not migrate during this part of the study.
Figure 1. Biodegradable gel pads.
Figure 2. Location of 2 biodegradable
gel pads for AF in anterior (A, B) and
inferior (C) views of heart.and Cardiovascular Surgery ● Volume 134, Number 6 1521
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1
EThe induced AF was terminated in all 6 pigs while the chest
as open by delivering an atrial shock as follows: mean
nergy, 0.65  0.23 J; mean impedance, 97.6  5.52;
ean voltage, 98.9  16.6 V (Table 1). Figure 3 show
epresentative example.
hase II
able 2 describes the mean values obtained at the defi
ation threshold over the postoperative course of 1 week in
nother 6 pigs. The defibrillation threshold was achieved
ith the chest open at POD 0 and with the chest closed at
ODs 1, 3, 5, and 7. Table 2 shows the mean energ
ead impedance obtained at the defibrillation threshold. En-
rgy and voltage increased over time. Impedance signifi-
antly differed between POD 0 and the other days, perhaps
ecause of the chest being open or closed. All induced AF
as cardioverted to sinus rhythm over a period of 1 week
fter surgery. No early recurrence of AF was evident within
minute after a primary cardioversion. On POD 10, all
ardioversion wires were easily removed by the simple
ranscutaneous traction that is used to remove temporary
ardiac pacing wires. No complications were related to lead
xtraction, and no bleeding was detected when the chest was
nspected after the animal was sacrificed at the predeter-
ined POD.
Gross and histologic assessment at 1 month after the
urgery confirmed that the gel pads dissolved. Mild inflam-
ABLE 1. Mean values obtained at lowest defibrillation
hreshold for atrial fibrillation
nimal No. Energy (joules) Impedance (ohms) Voltage (volts)
1 0.60  0.20 94.8 9.24 95.0  15.0
2 0.70  0.24 99.6 1.50 104.6  16.0
3 0.60  0.20 98.4 5.34 94.8  15.1
4 0.70  0.24 97.2 2.40 102.4  18.1
5 0.70  0.24 99.6 2.33 102.0  17.6
6 0.60  0.20 96.2 5.78 94.8  14.6
Total 0.65  0.23 97.6 5.52 98.9  16.6
eans  SD.522 The Journal of Thoracic and Cardiovascular Surgery ● Dec-
nd
ation predominantly comprised lymphocyte with foreign
ody giant cells on the gel pad. Phagocytes of the gel
ragments absorbed by foreign body giant cells were often
dentified. Mild fibrosis with fibroblast infiltration was also
vident on the gel pad. Inflammation was milder in the
picardium beneath than on the gel pad. In the myocardium
eneath the gel pad, few inflammatory cells were evident
nd the degree of inflammatory reactions was similar to that
f other epicardium and myocardium of the same heart that
id not contact the gel pad (Figure 4).
iscussion
ostoperative AF is often regarded as a benign clinical
ondition, but it has been associated with adverse outcomes,
ncluding patient discomfort and anxiety, increased risk for
troke, hemodynamic instability, prolonged hospital stay,
nd increased hospital costs.6-8 A reduction in postoperativ
F was recently identified in an off-pump series, although
his remains an area of controversy.2 Nonetheless, off-pump
oronary artery bypass grafting surgery has not eliminated
he problem of postoperative AF. Currently applied antiar-
hythmics and anticoagulation might induce considerable
ide effects, such as new arrhythmias. If all patients receive
outine prophylaxis, then approximately 70% of them
ould be exposed to unnecessary treatment and possible
ndesirable side effects. Transthoracic cardioversion also
as the side effect of causing new arrhythmias, burns, and
ain, as well as problems with anesthesia. Despite improve-
ents in technical advances, myocardial protection, cardio-
ulmonary bypass, and treatment over the last 50 years in
ardiac surgery, the incidence of postoperative AF has re-
ained unchanged.
This study demonstrated that atrial defibrillation using
emporary epicardial cardioversion gel pads placed on the
ight and left atria in a pig model can be effective and
afe, and use remarkably little energy not only with the
hest open intraoperatively (phase I) but also with the
hest closed postoperatively (phase II) as an alternative
herapy to postoperative AF. In addition, we evaluated a
hysiologic pericarditis model of AF that was suggested
Figure 3. Example of atrial defibrilla-
tion in pig model of pericarditis with
biodegradable cardioversion gel pads.
ECG, electrocardiogram; PV, pulmo-
nary vein.ember 2007
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ETy the common occurrence of atrial arrhythmias in pa-
ients after cardiac surgery and their association with the
ime course of pericarditis.15,16 We also defined the d-
brillation threshold as the lowest shock required to elicit
consecutive cardioversions, because no single amount
f energy can be defined as an absolute threshold and the
pper boundary of the defibrillation curve becomes more
ccurately defined, allowing smaller efficacy margins to
nsure 100% defibrillation.17 This clinical counterpar
enders the model reasonably relevant to patients after
ardiac surgery in terms of both the arrhythmia mecha-
ism and the time course, and thus is a logical choice of
herapy for postoperative AF.18
Our gel pad consists of cationic poly (-lysine) and
nionic HA, which is an important component of the
xtracellular matrix and connective tissues such as carti-
age. HA has been applied for medical purposes as a
iscoelastic biomaterial in ophthalmologic surgery and as
viscosupplementation agent for the treatment of joint
isease in orthopedics.19-22 In addition, HA is included 
osmetics because of its high water-retention capacity
nd in drug-delivery systems because of its biodegrad-
bility. The biocompatible counter polycation of poly
-lysine) can be easily conjugated with bioactive mole-
ABLE 2. Changes over time of mean values obtained at d
POD 0
nergy (J) 0.83 0.24 1.00 0.50 1.83
mpedance () 100.3  6.69 67.4 5.19* 69.4
oltage (V) 111.6 17.8 116.9 28.2 157.1
OD, Postoperative day. *Versus POD 0 value (.05). †Versus POD 1 valuThe Journal of Thoracicules.23 Furthermore, EPL is widely applied to prom
ell adhesion to solid substrates. Schwann cell attach-
ent significantly increases when crosslinked HA strands
re coated with polylysine.24 We applied the cell adh-
ion properties of polyelectrolyte gels with HA and EPL
o tissue surface attachment and constructed a biocom-
atible, biodegradable gel pad.
linical Implications
his pilot study demonstrates the potential clinical utility of
ow-energy cardioversion using biodegradable electrode gel
ads in the management of AF in patients after cardiac
urgery. Instead of external cardioversion requiring a gen-
ral anesthetic, which often causes cardiac depression in
atients with already diminished cardiac output and coro-
ary blood flow, only mild sedation is required, and internal
ardioversion can be used to restore sinus rhythm. Low-
nergy internal cardioversion might be an alternative in
atients with high transthoracic impedance, such as those
ho are obese or have chronic obstructive lung disease.
his therapy would provide a quick method of termination
f AF without having to resort to a large external cardio-
ersion shock or antiarrhythmic drugs.
rillation threshold for atrial fibrillation
5 7 Overall values
90 2.00 1.00 2.67 0.94 1.67  1.00
79* 68.9 3.75* 73.7 3.66*† 75.9  13.3
.7 164.3 39.8* 192.4 37.3*†‡ 148.5  45.0
05). ‡Versus POD 3 value (.05). Means  SD.
Figure 4. Gross (A, B) and histologic
(C, D) assessments 1 month after sur-
gery. Bar  1000 m. Epicardium and
myocardium beneath (C) and without
(D) gel pads. POD, Postoperative day.efib
1
 0.
 5.
 37and Cardiovascular Surgery ● Volume 134, Number 6 1523
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1
ETRecent pilot studies using temporary epicardial wire
lectrodes placed on the right and left atria of patients
emonstrated that atrial defibrillation can be accomplished
y shocks at low energy ranging from 5 to 6 J.10,12,13
ow-energy cardioversion using biodegradable gel pads can
e performed without complicated and time-consuming lead
lacement, which is required in cardioversion using tempo-
ary epicardial wire electrodes, and without risk of bleeding
fter removing the wire because of its biodegradability.
lthough low-energy shocks with biodegradable gel pads
ardioverted the atria in our animal model, it remains un-
nown whether the shock energies as low as 2 J that worked
n pigs will be as successful in human beings. We did not
valuate the correlation between energy level and pain
hreshold using this system. Other systems using temporary
picardial defibrillation wire electrodes have defibrillated
he atria with low-energy shocks. When energy shocks as
ow as 1 J are delivered, shock-related discomfort is expe-
ienced by most patients. Therefore, whether this system
an be tolerated without sedation remains uncertain. Al-
hough general anesthesia might be elective, mild sedation
ight be required to reduce patient discomfort. However, a
ignificant portion of patients are at risk for the development
f AF after cardiac surgery. Such patients might benefit
rom the use of biodegradable gel pads that are easy to affix,
specially during off-pump surgery, if they can provide
ffective and safe low-energy atrial cardioversion. We sug-
est that the utility of these pads be examined in patients.
tudy Limitations
he main limitation of this study is that AF was induced
n normal pig hearts. The substrates might differ between
umans and pigs. In addition, the pigs had not undergone
bypass and did not have atriotomy. Therefore, it re-
ains to be seen whether diseased hearts with AF in the
linical setting will respond like the pig hearts. However,
tudies of animals and patients with epicardial defibril-
ation wire electrodes placed on the right and left atria
howed that AF can be converted to sinus rhythm with
ow-energy shocks.10-14 The results of these pilot stud
ith epicardial defibrillation wire electrodes have been
ncouraging and indicate that similar success using low-
r-energy shocks is achievable in patients using the bio-
egradable gel pads. Nonetheless, because little is known
bout the toxicity of the biocompatible gel pad, further
nimal studies in vivo are required.
onclusions
he amount of energy required for atrial defibrillation using
ovel biodegradable cardioversion gel pads in a pig model
as well less than 2 J. The advantages of this system are
asy placement, straightforward removal of the wires, and
uick and safe atrial shock application. Atrial cardioversion
524 The Journal of Thoracic and Cardiovascular Surgery ● Decsing biodegradable gel pads that are easy to affix may
omprise a straightforward and effective treatment for AF
fter cardiac surgery.
We thank Drs Isao Matsumoto and Hideki Takeda for their
elpful suggestions and valuable technical assistance in conduct-
ng the study and Drs Misato Kasashima and Yoko Tanaka for
heir helpful suggestions and assistance in examining the histo-
ogic specimens.
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